匯川技術(300124.SZ):開發創新的All-liqcool全液冷儲能終端,支持產業下游構建分佈式電能存儲能力
格隆匯5月5日丨有投資者在投資者互動平台向匯川技術(300124.SZ)提問,“特斯拉要在上海建立儲能產品超級工廠,公司在儲能產品這塊佈局如何?”
匯川技術回覆稱,儲能是公司戰略業務能源管理的一部分,在整個能源管理板塊,隨着能源管理業務規劃的進一步完善,公司過去一年系統性地佈局了光儲、儲能、特種電源等產品,包括:①重點打造工商業一體機產品,鋪墊工商業市場。②佈局20KW光儲逆變器產品平台,逐步探索海外光儲市場。③推出200KW組串式儲能方案,初步完成市場試機工作。④開發創新的All-liqcool全液冷儲能終端,支持產業下游構建分佈式電能存儲能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.